Education Library

Resources for Health Care Professionals

Condition

Audience

Topic

Type

Questions to Ask When Caring for an Impella® Patient

January 6, 2020

Jason Richard, an advanced Impella® trainer, reviews questions to ask when taking over care of a patient with an Impella® heart pump. 

Discover New Data on Protected PCI versus Bailout PCI

January 6, 2020

Alexander Truesdell, MD, discusses Protected PCI versus bailout PCI using data from the cVAD Study and the PROTECT III study. 

Tips, Tricks and Techniques for High-Risk PCI

January 3, 2020

Amir Kaki, MD discusses tips, tricks and techniques for high-risk PCI including access, implant, explant, closure, and complications and sheath management.

Learn How Impella Affects Hemodynamics

December 19, 2019

Jo Kajewski, Global Impella® Trainer, uses a bedside monitor simulator to demonstrate how the Impella heart pump affects a patient's hemodynamics.

Cardiogenic Shock Heart Recovery Case Study with Impella® Support Prior to Complete Revascularization

December 16, 2019

James Park, MD, presents a patient with cardiogenic shock supported with the Impella heart pump prior to revascularization and describes other best practices at his center.

PROTECT Series of Clinical Studies Provides Mounting Evidence for Impella® Support in High-risk PCI

November 26, 2019

Impella “reduced major adverse events, critical care and readmission length of stay, and readmission cost over the 90-day EOC (episode of care), and was determined to be cost-effective over the long-term.”

Amin Analysis: Review of Trends, Variation and Outcomes in Impella® Use

November 17, 2019

Seth Bilazarian, MD, reviews the shortcomings of the Amin, et al., analysis presented at AHA 2019.

How Do Bleeding Rates with Impella® Compare to Bleeding Rates Associated With Other Forms of Mechanical Circulatory Support?

November 15, 2019

Data from the PROTECT II randomized controlled trial show that patients treated with Impella had numerically lower rates of vascular complications compared with patients treated with intra-aortic balloon pump (1.4% for Impella versus 1.9% for IABP).1

George Vetrovec, MD, Discusses Impella® Cost-Effectiveness

November 15, 2019

Dr. George Vetrovec discusses data showing the cost-effectiveness of PVADs, including Impella, in high-risk PCI and cardiogenic shock. 

Techniques to Reduce Bleeding with Large Bore Access Devices

November 13, 2019

Amir Kaki, MD, discusses techniques and best practices for access and closure to reduce bleeding and complications with large-bore access devices.

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

October 30, 2019

Babar Basir, DO, discusses NCSI study findings on right ventricular dysfunction in AMI cardiogenic shock.

LVEF Improvement After Complex High-Risk Case with Impella® Support

October 21, 2019

Rustem Dautov, MD describes a complex high-risk case in which he feels the Impella® heart pump was vital to patient survival.

SmartAssist® Facilitates Impella® Weaning and Explant Decision Making

October 16, 2019

Dr. Rajan Patel discusses how SmartAssist technology helps him make Impella weaning and explant decisions in high-risk PCI cases.

Impella Connect® System and SmartAssist® Technology Facilitate Impella® Support in Cardiogenic Shock Case

October 16, 2019

Impella Connect and SmartAssist help Rajan Patel, MD and his team manage an Impella-supported cardiogenic shock case as well as other cases.

PROTECT III Data Continues to Demonstrate Reduced MACCE with Impella®

October 15, 2019

Jeffrey Popma, MD, presents new PROTECT III data and safety and efficacy analyses from the PROTECT II randomized controlled clinical trial. 

NPS-1674